> Canada's QLT says it will fight an injunction blocking the sales of its pancreatic cancer therapy Eligard. A federal court in Illinois granted the injunction against the sale or marketing of Eligard until May 1. The injunction was sought by TAP Pharmaceuticals, which claims that QLT and Sanofi-Aventis violated their patent. The court, which stayed its ruling for seven days, also ordered a voluntary recall of the therapy. Report
> Advanced Life Sciences of Woodridge, IL has raised $36 million through a private placement of stock. Release
> With officials testing for bird flu in Ethiopia and Kenya and fresh signs of the virus cropping up in domestic poultry in Europe, UK officials have begun preparing for what they see as the inevitable arrival of the virus in their country. Scientists believe that once it does arrive in the UK, the virus will become endemic, staying for five years or more. The situation in Europe is already equivalent to "living under machine gun fire." Article
> Public Citizen is demanding the removal of the painkiller Darvocet from the market, claiming it is addictive, is no safer than alternatives and has been linked to more than 2,000 accidental deaths. Release
> Germany's Artemis Pharmaceuticals has agreed to create genetically engineered murine models for Bristol-Myers Squibb's drug discovery work. Release
> Business Objects and IBM have partnered up to offer a better way to identify potential candidates for research studies as well as predicting "at risk" patients based on their similarity to a patient cluster--ultimately improving the effectiveness of diagnosis and treatment. Release
> Biogen Idec has been ordered to turn over MRIs of a woman who died after taking Tysabri. The widower of Anita Smith sued Biogen Idec, saying that she did not have multiple sclerosis when she signed on to a trial of Tysabri in combination with Avonex. Report
> Australian scientists have published research on removing cells that are potentially cancerous. Report
> A judge has set a June 6 court date for the first trial involving Celebrex. Report
> Pfizer has shuffled management duties at its US pharmaceuticals division. Report
> Antares Pharma plans to raise $11 million through a private placement. Report
> King Pharmaceuticals has reached agreement on a patent dispute with Sanofi-Aventis Deutschland and Cobalt Pharmaceuticals. Report
And Finally… Heart disease is harder to detect in women, which makes it consequently more deadly. Article